SNHG16

ncRNA information

ncRNA name

SNHG16

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-338-3p/PLK4

Cancer information

Cancer name

Neuroblastoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells

Tissue resource

neuroblastoma tissues

neuroblastoma cell lines SK-N-AS

Experiment

None


Institute

Luoyang Central Hospital Affiliated To Zhengzhou University

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian